3D Liver Microstissues Composed of Human Primary Hepatocytes and a Mixture of Human Primary Hepatocyte, Liver Endothelial Cells and Kupffer Cells
Waiver type - Procurement: Nonavailability
Agency: NATIONAL INSTITUTES OF HEALTH (7529) • Product Service Code (PSC) : 6640 | Last Modified: 05/17/2023
Procurement Summary
This requirement is for the following commercial item, 3D Liver Microtissues Composed of Human Primary Hepatocytes and a Mixture of Human Primary Hepatocyte, Liver Endothelial Cells and Kupffer. The National Cener for Advancing Translational Sciences (NCATS) requires 3D live microtissues composed of human primary hepatocytes and a mixture of human primary hepatocyte, liver endothelial cells and Kupffer cells. These 3D liver microtissues will be used to study viral infectivity, effects of viral infectivity on liver function biomarkers, and effect of anti-viral compounds on viral infection. The liver microtissues of different cell type composition will allow NCATS to assess the role of the different cell types on the readouts above. If successful, this assay platform of 3D liver microtissues might be integrated in a panel of tissues to study panels of viruses and anti-infective drugs.
No
Yes
Consistent with Policy
LABORATORY EQUIPMENT AND SUPPLIES
325414 - Biological Product (except Diagnostic) Manufacturing
05/10/2023
N/A
75N95023Q00181
Post-solicitation
Between 6 months and 1 year
Individual Waiver
NATIONAL INSTITUTES OF HEALTH